A clinician draft note in an EHR sidebar reads "Prior Authorization Requested" next to a mood stabilizer prescription — and a patient on the other side of a video call is wondering why their medication isn't at the pharmacy yet. Prior authorization is one of the most friction-generating processes in psychiatric care, and one of the least understood by patients navigating it for the first time. This article explains what prior authorization is, which psychiatric medications commonly require it, how the process works in telehealth practice, and what your rights are when a PA is denied.

Prior authorization exists because insurers require clinical justification before covering certain medications — usually those that are more expensive, have abuse potential, or for which lower-cost alternatives exist. The PA requirement is not specific to telehealth; it applies equally to in-person prescribers. What differs in telehealth is how the administrative process is handled and communicated to you.

Which Psychiatric Medications Commonly Require Prior Authorization

Prior authorization requirements vary by insurer and plan, but certain categories of psychiatric medications trigger PA requirements with high frequency across most major commercial payers. Brand-name stimulants for ADHD — particularly extended-release formulations — routinely require PA, with some plans requiring documentation that a generic formulation was tried first. Certain atypical antipsychotics, particularly newer agents or those with significant cost differentials, require PA for conditions including bipolar disorder and PTSD augmentation. Some newer antidepressants, particularly branded SNRIs and medications in the serotonin modulator class, may require PA after first-line SSRI trials.

Generic formulations of well-established medications — sertraline, fluoxetine, methylphenidate, generic amphetamine salts — rarely require PA. Most PA requirements exist to channel prescribing toward lower-cost alternatives first, or to confirm a specific clinical indication before covering a more expensive agent.

How the PA Process Works

When your Legion Health provider prescribes a medication that requires prior authorization, the following typically occurs: your provider or our billing team submits a PA request to your insurer with clinical documentation — your diagnosis, the clinical rationale for the specific medication, and in some cases documentation of prior medication trials and their outcomes. The insurer reviews the submission against their clinical criteria and issues an approval or denial, typically within 3 to 10 business days depending on the insurer and plan type.

For urgent clinical situations — patients who cannot wait 7 to 10 days for a PA decision on a medication addressing acute symptoms — most insurers have an expedited or urgent review process that shortens the timeline to 24 to 72 hours. Your provider can flag urgency in the submission.

“Prior authorization is not a medical decision — it is an administrative one. If your insurer denies a PA, that denial can be appealed, and your provider can participate in a peer-to-peer review with the insurer's medical reviewer.”

Bridge Medications While Awaiting PA

When a PA is pending for a medication that is clinically important, your provider may prescribe a bridge medication — a clinically appropriate alternative that does not require PA — to avoid a gap in treatment while the authorization is processed. For example, a generic stimulant formulation while a PA for a specific extended-release brand is pending. Your provider will discuss the bridge option explicitly; no medication change should happen without your knowledge.

When Prior Authorization Is Denied

PA denial does not mean the medication decision was wrong — it means the insurer's administrative criteria were not satisfied by the initial submission. Most denials can be challenged. The two most effective paths are a peer-to-peer review, in which your prescribing provider speaks directly with the insurer's medical reviewer, and a formal appeal, which goes through the insurer's internal appeals process and is subject to federal timelines under the ACA.

If you receive a PA denial notification, contact your Legion Health care team immediately. Do not assume a denial is final. Research and advocacy organizations have documented that a meaningful proportion of denied PA requests are reversed through peer-to-peer review or first-level appeal when the clinical case is well-documented. Your provider's team handles this process on your behalf.

Step Therapy and "Fail First" Requirements

Some insurers require "step therapy" — a requirement that a patient try and fail a lower-cost medication before the requested medication is covered. For psychiatric medications, this can mean being required to try a generic antidepressant before a newer agent, or a generic stimulant before a specific extended-release formulation. Step therapy requirements must be disclosed to you, and your provider can document clinical exceptions when the step requirement is medically inappropriate for your specific situation.

Federal and state protections exist against step therapy protocols that create clinically inappropriate barriers. APA and NAMI have advocated for and won step therapy reform laws in many states that require expedited clinical exception processes. Your provider is aware of your state's protections and can invoke them in the PA process.

How Legion Health Handles Prior Authorization

Legion Health's billing and care coordination team manages PA submissions as a standard part of the care relationship — you are not responsible for initiating or managing the PA paperwork. When a PA is required, our team contacts your insurer, submits the clinical documentation provided by your provider, and monitors the status. If a denial or additional information request comes back, we coordinate with your provider and notify you promptly.

Source Notes

  • American Medical Association. 2023 AMA Prior Authorization (PA) Physician Survey. AMA, 2023.
  • American Psychiatric Association. Prior Authorization and Step Therapy: APA Policy Statement. APA, 2022.
  • Centers for Medicare and Medicaid Services. Prior Authorization Overview and Consumer Protections. CMS.gov, 2024.
  • National Alliance on Mental Illness (NAMI). Insurance Coverage for Mental Health: Step Therapy Reforms. NAMI.org, 2023.
  • KFF Health Policy. Prior Authorization in Marketplace Plans: Implications for Mental Health Access. 2022.

This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider for diagnosis and treatment of any medical condition. Legion Health is not an emergency service. If you are in crisis, call or text 988 or go to your nearest emergency room.